Ubrelvy (Ubrogepant) for Migraine | MyMigraineTeam

Connect with others who understand.

sign up log in
About MyMigraineTeam
Powered By

Ubrelvy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an acute treatment for migraine in adults. Ubrelvy is also referred to by its drug name, ubrogepant.

Ubrelvy is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the receptor that CGRP (a protein that can cause migraine headaches) uses to react with the body.

How do I take it?
Prescribing information states that Ubrelvy is available as tablets taken by mouth as needed. You can take Ubrelvy with or without food.

Side effects
The FDA-approved label for Ubrelvy lists common side effects including sleepiness and nausea. Allergic reactions are also possible.

For more details about this treatment, visit:

Ubrelvy — Abbvie

UBRELVY- ubrogepant tablet — DailyMed

Ubrogepant (Oral Route) — Mayo Clinic

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of Use and Privacy Policy.
Already a Member? Log in